Clinical Resource Core

临床资源核心 节目摘要/摘要 糖尿病是一种世界性的健康危机，1型糖尿病(T1D)和2型糖尿病的发病率都很高 糖尿病(T2D)稳步增加。虽然自身免疫是T1D的核心，但这种疾病的许多关键方面 T1D和T2D共同的过程包括β细胞功能障碍、高血糖、代谢功能障碍和 胰岛素抵抗。T1D和T2D的并发症也有许多相似之处，包括心血管疾病 心血管疾病(CVD)和糖尿病肾病(DKD)，这两种疾病都是导致发病率和死亡率的主要原因。伊利诺伊大学 科罗拉多州安舒茨医学中心(UC AMC)是临床转化研究领域的世界领先者之一 T1D和T2D在整个生命周期中以及在妊娠期糖尿病(GDM)和囊性纤维化相关糖尿病中 (CFRD)。通过糖尿病研究中心(DRC)提供的资金将利用这些现有的 优势和催化形成一个综合的全面的糖尿病研究计划。 加州大学丹佛分校DRC的临床资源核心(CR)站在多个机构、项目的界面上 以及个人，所有这些人都在努力预防或改善 糖尿病及其沉重的经济负担。CR核心将利用当前的临床研究设施和 加州大学AMC临床翻译中心芭芭拉·戴维斯儿童糖尿病中心(BDC)提供的设备 科罗拉多大学医院研究中心(CTRC)，丹佛退伍军人管理医疗中心 (弗吉尼亚州)和科罗拉多州儿童医院。DRC CR核心将整合这些领域的糖尿病研究 机构通过沟通和分配可用的资源，并创建共享的样本和 数据生物库和母亲、婴儿、儿童、青少年和成年糖尿病患者的招募数据库， 糖尿病风险和控制。这样的整合将加快进展并提高糖尿病的质量 研究、整合现有优势，并从战略上集中在需要的领域招聘教师 成长。DRC的资金也将吸引研究生和初级教员水平的新人才，并增加 发现所需的基础设施的独特组件。 具体地说，我们将改善招募对象、跟踪数据和银行组织的访问和协作 从患有糖尿病的表型良好的参与者和整个生命周期的对照组受试者身上采集样本；建立 收集我们具有良好特征的对象的样本，并促进DRC用户的能力 利用最先进的技术从外周血、血清和血浆中进行分析；改进提供 专业的诊断和分析服务。

CLINICAL RESOURCE CORE PROGRAM SUMMARY/ABSTRACT Diabetes represents a worldwide health crisis, with the incidence of both type 1 diabetes (T1D) and type 2 diabetes (T2D) steadily increasing. While autoimmunity is central to T1D, many key aspects of the disease process are shared by T1D and T2D, including beta cell dysfunction, hyperglycemia, metabolic dysfunction and insulin resistance. Complications of T1D and T2D also have many similarities, including cardiovascular disease (CVD) and diabetic kidney disease (DKD), both leading causes of morbidity and mortality. The University of Colorado Anschutz Medical Center (UC AMC) is among world leaders in clinical translational investigations into T1D and T2D across the lifespan, as well as in gestational diabetes (GDM) and cystic fibrosis-related diabetes (CFRD). Funding through the Diabetes Research Center (DRC) would capitalize on these existing strengths and catalyze the formation of an integrated comprehensive diabetes research program. The Clinical Resource Core (CR) of the UC Denver DRC stands at the interface of multiple institutions, programs and individuals, all of whom are working to prevent or ameliorate the devastating long term complications of diabetes and its high economic burden. The CR core would leverage the current clinical research facilities and equipment available at the Barbara Davis Center for Childhood Diabetes (BDC), UC AMC’s Clinical Translational Research Center (CTRC), The University of Colorado Hospital, Denver Veteran’s Administration Medical Center (VA) and Children’s Hospital Colorado. The DRC CR core would integrate diabetes research across these institutions through communication and distribution of the resources available, and create shared sample and data biobanks and a recruiting database of mothers, infants, children, adolescents and adults with diabetes, diabetes risk and controls. Such integration would accelerate progress and increase the quality of diabetes research, coalesce existing strengths and strategically focus faculty recruitment in areas of needed growth. DRC funding would also attract new talent at postgraduate and junior faculty levels and add unique components of infrastructure needed for discovery. Specifically, we will improve access and collaborations for recruiting subjects, tracking data and banking tissue samples from well-phenotyped participants with diabetes and control subjects across the lifespan; establish collections of samples from our well-characterized subjects and facilitate the ability of DRC users to perform assays from peripheral blood, serum and plasma utilizing state of the art techniques; improve provision of specialized diagnostic and analytic services.